Gate2Brain raises $7.5M unknown (Spain, Jun 2026)
$7.5M
€7 millionGenerated social card
Headline
Barcelona-based Gate2Brain secures €7 million to advance brain tumour candidate - EU-Startups
About
Gate2Brain is a Spanish biotech company focused on developing therapeutic candidates for aggressive pediatric and adult brain tumors. The company aims to address high unmet medical needs in central nervous system diseases by enabling therapeutics to cross the blood-brain barrier using its proprietary technology platform.
Article summary
Barcelona-based Gate2Brain secures €7 million to advance brain tumour candidate EU-Startups
Founder
Dr. Meritxell Teixidó
CEO & CSO
Investors · 1
Shilpa Biocare Pvt LtdLead
FUND
Related rounds
| Jul 27, 2026 | Multiverse Computing | $570.0M | Series C | Spain |
| Jun 17, 2026 | NeuralTrust | $20.0M | Seed | Spain |
| Jun 15, 2026 | Orbio | $21.0M | Series A | Spain |
| Jun 11, 2026 | THEKER | $78.0M | Series A | Spain |